Literature DB >> 11903374

Temporomandibular joint dysfunction following tonsillectomy.

Sangeeta Maini1, J E Osborne, H M S Fadl, C Spyridakou, L Ogunyemi, P Hill.   

Abstract

We report a prospective, controlled trial to assess temporomandibular joint (TMJ) dysfunction following the use of a Boyle-Davis mouth gag during tonsillectomy. TMJ function was evaluated in patients undergoing tonsillectomy and a control group undergoing nasal surgery preoperatively and 6 weeks postoperatively. The main outcome measures were symptoms and signs of TMJ dysfunction and interincisal distance. A mean reduction of 0.89 mm in interincisal distance (P < 0.01) was noted postoperatively in the tonsillectomy patients. There was no statistically significant reduction of interincisal distance in patients undergoing nasal surgery. There was a statistically significant reduction in interincisal distance in the post-tonsillectomy patients, caused by fibrous healing of the tonsillar bed or fibrous ankylosis of the TMJ.

Entities:  

Mesh:

Year:  2002        PMID: 11903374     DOI: 10.1046/j.0307-7772.2001.00528.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  3 in total

1.  Beneficial effects of dexmedetomidine on early postoperative cognitive dysfunction in pediatric patients with tonsillectomy.

Authors:  Chuanlai Han; Rong Fu; Weifu Lei
Journal:  Exp Ther Med       Date:  2018-05-17       Impact factor: 2.447

Review 2.  Malpractice claims and unintentional outcome of tonsil surgery and other standard procedures in otorhinolaryngology.

Authors:  Jochen P Windfuhr
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2013-12-13

3.  Evaluation of the effect of the mouth gag use on optic nerve sheath diameter of pediatric patients undergoing tonsillectomy or Adenotonsillectomy: An observational study.

Authors:  Başak Altiparmak; Melike Korkmaz Toker; Ali İhsan Uysal; Sabri Köseoğlu; Semra Gümüş Demirbilek
Journal:  BMC Anesthesiol       Date:  2020-07-03       Impact factor: 2.217

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.